AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

AXB

70.1

-0.28%↓

BRKB

513.81

+1.3%↑

BRKA.US

770,370

+1.28%↑

JPM

267.4

+0.02%↑

V

365.09

+0.75%↑

Search

KKR & Co LP

Geschlossen

BrancheFinanzen

125.83 0.2

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

124.57

Max

126.46

Schlüsselkennzahlen

By Trading Economics

Einkommen

-700M

684M

Verkäufe

-90M

3.1B

KGV

Branchendurchschnitt

38.177

24.598

EPS

1.15

Dividendenrendite

0.59

Gewinnspanne

22.008

Angestellte

4,834

EBITDA

-17M

1.5B

Empfehlungen

By TipRanks

Empfehlungen

Starkes Kaufsignal

12-Monats-Prognose

+9.8% upside

Dividenden

By Dow Jones

Dividendenrendite

Branchendurchschnitt

0.59%

4.30%

Nächstes Ergebnis

30. Juli 2025

Nächste Dividendenausschüttung

27. Mai 2025

Nächstes Ex-Dividendendatum

11. Aug. 2025

Marktstatistiken

By TradingEconomics

Marktkapitalisierung

9.9B

116B

Vorheriger Eröffnungskurs

125.63

Vorheriger Schlusskurs

125.83

Nachrichtenstimmung

By Acuity

21%

79%

45 / 540 Ranking in Finance

Technischer Score

By Trading Central

Vertrauen

Bullish Evidence

KKR & Co LP Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

1. Mai 2025, 14:11 UTC

Ergebnisse

KKR Swings to 1Q Loss, Asset Management Sales Rise

30. Apr. 2025, 14:14 UTC

Akquisitionen, Fusionen, Übernahmen

GlobalData Gets Takeover Approaches From KKR, ICG Europe Fund

22. Apr. 2025, 06:50 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Launches $1.2 Billion Takeover Bid For Swedish Life-Sciences Company Biotage

14. Apr. 2025, 11:46 UTC

Akquisitionen, Fusionen, Übernahmen

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1 Billion Deal

9. Apr. 2025, 10:24 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR

9. Apr. 2025, 07:09 UTC

Akquisitionen, Fusionen, Übernahmen

Assura Accepts $2 Billion Takeover Offer From KKR Consortium

9. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Nears $2.85 Billion Deal With EQT For E45 Maker Karo Healthcare, FT Reports, Citing Sources

7. Apr. 2025, 14:42 UTC

Akquisitionen, Fusionen, Übernahmen

Assura Agrees to Primary Health Properties Bid Deadline Extension

1. Mai 2025, 10:55 UTC

Ergebnisse

KKR Declares Qtrly Div of 18.5/Share >KKR

1. Mai 2025, 10:54 UTC

Ergebnisse

KKR 1Q Rev $3.11B >KKR

1. Mai 2025, 10:54 UTC

Ergebnisse

KKR 1Q Insurance Revenue $1.06B >KKR

1. Mai 2025, 10:54 UTC

Ergebnisse

KKR 1Q Asset-Management and Strategic Holdings Revenue $2.05B >KKR

1. Mai 2025, 10:54 UTC

Ergebnisse

KKR 1Q-End Assets Under Management $664B >KKR

1. Mai 2025, 10:54 UTC

Ergebnisse

KKR 1Q Fee-Related Earnings $823M, or 92c/Adj. Share >KKR

1. Mai 2025, 10:53 UTC

Ergebnisse

KKR 1Q Loss/Shr 22c >KKR

22. Apr. 2025, 06:04 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Price Represents 60% Premium to Thursday's Closing Price

22. Apr. 2025, 06:03 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Biotage Board Recommends Shareholders Accept Offer

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Offer Values Biotage at SEK11.61B

22. Apr. 2025, 06:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Makes SEK145 a Share Bid For Biotage

18. Apr. 2025, 00:00 UTC

Top News

Private Equity World Engulfed by Perfect Storm -- WSJ

14. Apr. 2025, 11:31 UTC

Top News
Akquisitionen, Fusionen, Übernahmen

CME Group, S&P Group Agree to Sell OSTTRA to KKR in $3.1B Deal

14. Apr. 2025, 11:02 UTC

Akquisitionen, Fusionen, Übernahmen

KKR: Making OSTTRA Investment Primarily Through North America Private-Equity Strategy >KKR

14. Apr. 2025, 11:01 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global, CME to Divide Sale Proceeds Evenly Pursuant to 50/50 Joint Venture >SPGI CME

14. Apr. 2025, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global, CME Group to Sell OSTTRA to KKR for $3.1 Billion >SPGI CME KKR

14. Apr. 2025, 11:00 UTC

Akquisitionen, Fusionen, Übernahmen

S&P Global and CME Group to Sell OSTTRA to KKR for $3.1 Billion

11. Apr. 2025, 11:56 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Now Owns 30% of Enilive

11. Apr. 2025, 11:55 UTC

Akquisitionen, Fusionen, Übernahmen

KKR Completes Acquisition of Additional Stake in Enilive

9. Apr. 2025, 09:51 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR for an Undisclosed Amount

9. Apr. 2025, 09:32 UTC

Akquisitionen, Fusionen, Übernahmen

EQT: Transaction Expected to Close in Coming Months

9. Apr. 2025, 09:31 UTC

Akquisitionen, Fusionen, Übernahmen

EQT to Sell Karo Healthcare to KKR

Peer-Vergleich

Kursveränderung

KKR & Co LP Prognose

Kursziel

By TipRanks

9.8% Vorteil

12-Monats-Prognose

Durchschnitt 141.67 USD  9.8%

Hoch 194 USD

Tief 119 USD

Basierend auf 12 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für KKR & Co LP – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

12 ratings

12

Buy

0

Halten

0

Sell

Technischer Score

By Trading Central

114.51 / N/AUnterstützung & Widerstand

Kurzfristig

Bullish Evidence

Mittelfristig

Neutral Evidence

Langfristig

Weak Bearish Evidence

Stimmung

By Acuity

45 / 540 Ranking in Finanzen

Nachrichtenstimmung

Sehr starke bullische Evidenz

Volatilität

Unterdurchschnittlich

Nachrichtenvolumen (RCV)

Unterdurchschnittlich

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

$

Über KKR & Co LP

KKR & Co. Inc. is a private equity and real estate investment firm specializing in direct and fund of fund investments. It specializes in acquisitions, leveraged buyouts, management buyouts, credit special situations, growth equity, mature, mezzanine, distressed, turnaround, lower middle market, and middle market investments. The firm considers investments in all industries with a focus on software, security, semiconductors, consumer electronics, internet of things (iot), internet, information services, information technology infrastructure, financial technology, network and cyber security architecture, engineering and operations, content, technology and hardware, energy and infrastructure, real estate, services industry with a focus on business services, intelligence, industry-leading franchises and companies in natural resource, containers and packaging, agriculture, airports, ports, forestry, electric utilities, textiles, apparel and luxury goods, household durables, digital media, insurance, brokerage houses, non-durable goods distribution, supermarket retailing, grocery stores, food, beverage, and tobacco, hospitals, entertainment venues and production companies, publishing, printing services, capital goods, financial services, specialized finance, pipelines, and renewable energy. In energy and infrastructure, it focuses on the upstream oil and gas and equipment, minerals and royalties and services verticals. In real estate, the firm seeks to invest in private and public real estate securities including property-level equity, debt and special situations transactions and businesses with significant real estate holdings, and oil and natural gas properties. The firm also invests in asset services sector that encompasses a broad array of B2B, B2C and B2G services verticals including asset-based, transport, logistics, leisure/hospitality, resource and utility support, infra-like, mission-critical, and environmental services. Within Americas, the firm prefers to invest in consumer products; chemicals, metals and m